This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in ProAssurance (PRA): Can Its 48.1% Jump Turn into More Strength?
by Zacks Equity Research
ProAssurance (PRA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
PRAPositive Net Change CNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in International General Insurance (IGIC): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
International General Insurance (IGIC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IGICPositive Net Change ORIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Carvana (CVNA) Soars 5.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Carvana (CVNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
CVNANegative Net Change BABANegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Onity (ONIT) Stock Jumps 12.2%: Will It Continue to Soar?
by Zacks Equity Research
Onity (ONIT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ONITNegative Net Change ESNTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
The Joint (JYNT) Stock Jumps 10.0%: Will It Continue to Soar?
by Zacks Equity Research
The Joint (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
JYNTPositive Net Change CNCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?
by Zacks Equity Research
Xeris Biopharma (XERS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
XERSPositive Net Change AUPHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Adma Biologics (ADMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ADMANegative Net Change WVEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
USCB Financial (USCB) Soars 5.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
USCB Financial (USCB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
USCBNo Net Change OBKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Blue Owl Capital (OWL) Moves 6.0% Higher: Will This Strength Last?
by Zacks Equity Research
Blue Owl Capital (OWL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OWLNegative Net Change JHGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Warby Parker (WRBY): Can Its 6.6% Jump Turn into More Strength?
by Zacks Equity Research
Warby Parker (WRBY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
WRBYNegative Net Change CLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength?
by Zacks Equity Research
Sarepta Therapeutics (SRPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
SRPTNegative Net Change MDXGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Vinci Partners (VINP): Can Its 5.2% Jump Turn into More Strength?
by Zacks Equity Research
Vinci Partners (VINP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
VINPPositive Net Change ALTINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Idaho Strategic Resources (IDR) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Idaho Strategic Resources (IDR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IDRNegative Net Change KGCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Synchronoss (SNCR) Moves 12.3% Higher: Will This Strength Last?
by Zacks Equity Research
Synchronoss (SNCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
SNCRNegative Net Change BILLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Xponential Fitness (XPOF) Moves 23.2% Higher: Will This Strength Last?
by Zacks Equity Research
Xponential Fitness (XPOF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
XPOFNegative Net Change THNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Yeti (YETI) Stock Jumps 5.7%: Will It Continue to Soar?
by Zacks Equity Research
Yeti (YETI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
YETINegative Net Change ONEWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ascendis Pharma (ASND) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ASNDPositive Net Change RGENNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Oxford Industries (OXM) Surges 7.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Oxford Industries (OXM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OXMNegative Net Change PVHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Aveanna (AVAH) Surges 6.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Aveanna (AVAH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AVAHPositive Net Change DGXNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Citizens (CIA) Surges 9.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Citizens (CIA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CIANegative Net Change GOCONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
EverQuote (EVER) Surges 5.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
EverQuote (EVER) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
EVERNegative Net Change FIHLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Astronics Corporation (ATRO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ATROPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength?
by Zacks Equity Research
BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BHSTNegative Net Change ARVNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
PennyMac Mortgage (PMT) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
PMTNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ARGXPositive Net Change STOKPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today